Regardless of the sequential decrease in Current Liabilities, during the third quarter 2026, Quick Ratio deteriorated to 0.82 below Neuronetics Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 112 other companies have achieved higher Quick Ratio than Neuronetics Inc in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 1921, from total ranking in the second quarter 2026 at 1959.

Explain Quick Ratio?
How much Cash & cash equivalents STIM�s has?
What are STIM�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/STIM/financial-strength

https://api.csimarket.com/api/v1/companies/STIM/fundamentals

https://api.csimarket.com/api/v1/companies/STIM/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

STIM Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	14.99 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-35.87 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.82	Subscribe	Subscribe	Subscribe	Subscribe
STIM's Total Ranking	# 1921	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	-5.13 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-11.39 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 113
Healthcare Sector	# 649
Overall Market	# 1921

Quick Ratio Statistics
High	Average	Low
11.77	3.43	0.7
(Mar 31 2021)		(Dec 31 2024)

Financial Statements
Neuronetics Inc 's Current Liabilities	$ 27 Millions	Visit STIM's Balance sheet
Neuronetics Inc 's Cash & cash equivalent	$ 22 Millions	Visit STIM's Balance sheet
Source of STIM's Sales		Visit STIM's Sales by Geography

Cumulative Neuronetics Inc 's Quick Ratio

STIM's Quick Ratio for the trailling 12 Months

STIM Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	11.66 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	10.51 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.97	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3967	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	3.52 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-10.99 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to STIM Financial Strength Comparisons >> Go to Compare STIM Quick Ratio to its Competitors

News about Neuronetics Inc Quick Ratio

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4): A Pioneering Approach to Attracting Top Talent and Encouraging Innovation

Neuronetics, a leading medical technology company specializing in creating innovative solutions for patients with neurohealth disorders, recently announced the issuance of Restricted Stock Units (RSUs) as inducement awards to sixteen new non-executive employees. These awards, totaling 55,200 shares, were granted to the employees in accordance with NASDAQ Listing Rule 5635(c)(4) and were approved by Neuronetics Compensation Committee as essential inducements to attract and retain top talent at the company.
Neuronetics commitment to improving the lives of individuals suffering from neurohealth disorders is evident through their unwavering dedication in developing and marketing groundbreaking medical products. By providing effective treatments and groundbreaking technologies, the company aims to enhance the quality of life for patients in need of neurological care.

Neuronetics Secures $90 Million Debt Facility with Perceptive Advisors, Improving Financial Health

In a recent announcement, Neuronetics, Inc. (NASDAQ: STIM) revealed that it has entered into a debt facility of up to $90 million with Perceptive Advisors LLC. This senior secured credit facility will provide Neuronetics with much-needed financial support as it continues to develop innovative medical technologies to improve the quality of life for patients with neurohealth disorders.
One particular highlight of this deal is the significant decrease in Neuronetics current liabilities, allowing for an improvement in the Quick Ratio to 3.5. Despite some fluctuations in the company s financial metrics, this partnership with Perceptive Advisors bodes well for Neuronetics future growth and success.

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2026 to $26.86 millions, cumulative Quick Ratio decreased to 0.97 below the average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 201 other companies have achieved higher Quick Ratio than Neuronetics Inc . While Quick Ratio overall ranking has improved so far to 3967, from total ranking during the twelve months ending second quarter 2026 at 4005.

Explain Quick Ratio?
How much Cash & cash equivalents STIM�s has?
What are STIM�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 202
Healthcare Sector	# 894
Within the Market	# 3967

trailing twelve months Quick Ratio Statistics
High	Average	Low
5.77	2.76	0.19
(Jun 30 2019)		(Jun 30 2018)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Atricure Inc	2.23	$ 187.031 Millions	$ 83.972 Millions
Vivani Medical Inc	2.22	$ 14.591 Millions	$ 6.585 Millions
Electromed Inc	2.19	$ 15.875 Millions	$ 7.261 Millions
Inspire Medical Systems inc	1.96	$ 190.803 Millions	$ 97.438 Millions
Aethlon Medical Inc	1.91	$ 6.487 Millions	$ 3.403 Millions
Merit Medical Systems Inc	1.90	$ 503.551 Millions	$ 265.083 Millions
Nephros Inc	1.89	$ 4.546 Millions	$ 2.409 Millions
Fractyl Health Inc	1.82	$ 31.515 Millions	$ 17.345 Millions
Warby Parker Inc	1.77	$ 287.914 Millions	$ 162.226 Millions
Anika Therapeutics Inc	1.68	$ 44.957 Millions	$ 26.725 Millions
EBR Systems, Inc.	1.63	$ 85.415 Millions	$ 52.539 Millions
Intuitive Surgical Inc	1.60	$ 4,042.500 Millions	$ 2,533.000 Millions
Tactile Systems Technology Inc	1.58	$ 75.110 Millions	$ 47.499 Millions
Edap Tms Sa	1.56	$ 56.269 Millions	$ 36.070 Millions
Neuraxis Inc	1.55	$ 4.477 Millions	$ 2.888 Millions
Envista Holdings Corporation	1.42	$ 1,158.800 Millions	$ 816.300 Millions
Inogen Inc	1.38	$ 96.840 Millions	$ 70.265 Millions
Intelligent Bio Solutions Inc	1.30	$ 5.930 Millions	$ 4.578 Millions
Si bone inc	1.20	$ 35.460 Millions	$ 29.619 Millions
Medline Inc	1.12	$ 3,608.000 Millions	$ 3,211.000 Millions
Pro dex Inc	1.10	$ 14.219 Millions	$ 12.884 Millions
Sanara Medtech Inc	1.09	$ 17.788 Millions	$ 16.282 Millions
Penumbra Inc	1.09	$ 254.282 Millions	$ 233.810 Millions
Koru Medical Systems Inc	1.08	$ 7.364 Millions	$ 6.792 Millions
Establishment Labs Holdings Inc	1.06	$ 75.812 Millions	$ 71.611 Millions
Globus Medical Inc	1.02	$ 517.435 Millions	$ 507.938 Millions
Envoy Medical Inc	0.98	$ 14.570 Millions	$ 14.861 Millions
Integra Lifesciences Holdings Corp	0.95	$ 311.930 Millions	$ 329.002 Millions
Myomo Inc	0.93	$ 11.946 Millions	$ 12.902 Millions
Strata Critical Medical Inc	0.92	$ 41.641 Millions	$ 45.118 Millions

Date modified: 2026-11-06T12:56:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.